Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703

Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703–711

Published:2022-01 Issue:1 Volume:81 Page:e22
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Takahashi Takeshi^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference5 articles.

1. Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations for 2021;Van Poppel;Eur Urol,2021

2. Systematic reviews in health care: assessing the quality of controlled clinical trials;Jüni;BMJ,2001

3. Early detection of cancer: past, present, and future;Schiffman;Am Soc Clin Oncol Educ Book,2015

4. Overdiagnosis and overtreatment in cancer: an opportunity for improvement;Esserman;JAMA,2013

5. PSA screening: a kind of Russian roulette?;Takahashi;J Gen Intern Med,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-Specific Antigen Screening Should Not Be Covered by Publicly Funded Health Insurance;JAMA Oncology;2023-06-01

2. Prostate‐specific antigen screening: A kind of Russian roulette regardless of race or risk;Cancer;2022-12-09

3. Public health perspective on prostate-specific antigen screening: Implications of overdiagnosis and differences in health insurance systems across countries;Journal of Medical Screening;2022-11-22

4. PSA screening in high-risk groups: what are the changes in benefits and harm?;British Journal of Cancer;2022-08-23